Virtual Reality Applied to the Evaluation and Rehabilitation of Locomotion - Study of Tolerance in the Lower Limb Amputee (REVA)

December 17, 2025 updated by: Centre Hospitalier Universitaire Dijon

The adaptability of the locomotor activity allows to face all the modifications of the immediate environment met in the daily activities. These situations become complex to apprehend for a person with a locomotor disability such as patients fitted with a lower limb amputation device. Thus, these adaptation capacities are essential to take into account in the rehabilitation process to maximize autonomy and reduce the risk of falls. For this purpose, the Quantitative Gait Analysis (QGA) allows to measure the impact of these constraining situations on the organization of gait patterns. However, this evaluation could be considerably optimized in current practice with the contribution of Virtual Reality (VR), by its immersive power which brings it closer to real life conditions (walking in a straight line, going up/down steps, taking into account visual and sound constraints, etc.). Eventually, this immersive approach by various VR environments could allow to improve the rehabilitation protocols in a personalized and secure way.

In this context, this project proposes to measure the tolerance of volunteers in a specific virtual environment and to quantify the modifications induced by this immersive environment, during a simple locomotor act (walking on flat ground) and complex (walking on a slope) in healthy volunteers, in order to evaluate the impact of VR on locomotion in a healthy population, and then in a second time in lower limb amputee patients

This monocentric study will take place on the Technological Investigation Platform of the Dijon Bourgogne University Hospital.

25 healthy volunteers and 25 lower limb amputees (transtibial or transfemoral) will be included in this study.

The participants will make 3 visits:

  • Visit 1 (inclusion visit and analysis of walking on flat ground)
  • visit 2 (analysis of walking on slopes): between 15 days and 1 month after visit 1
  • visit 3 (group interview with a sociologist): only for patients within 45 days after visit 2

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dijon, France, 21000
        • Chu Dijon Bourgogne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Healthy volunteers:

  • Person who has given oral consent
  • Male or female over the age of majority, < 80 years
  • Person able to understand simple commands, conditioning instructions

Amputee patients:

  • Person who has given oral consent
  • Male or female over the age of majority, < 80 years
  • Patients with unilateral transfemoral or transtibial amputation of the lower limb of any origin (traumatic, vascular, congenital or neoplastic) with a definitive device.
  • Patients with stable locomotion with aids, without technical aids
  • Person able to understand simple orders, conditioning instructions

Exclusion Criteria:

Healthy Volunteers:

  • Person who is not affiliated or not a beneficiary of a social security system
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a legal protection measure
  • Pregnant, parturient or breastfeeding woman
  • Major incapable or unable to express his consent
  • Minor
  • Person with locomotor disorders (orthopedic, neurological, vascular, cardiac...) and/or balance disorders that may significantly alter walking
  • Person with a contraindication to wearing a virtual reality helmet (uncontrolled epilepsy, wound of an area that the helmet would cover, severe ophthalmological disorders etc.)

Amputee patients:

  • Person who is not affiliated or not a beneficiary of a social security plan
  • Person under legal protection (guardianship, trusteeship)
  • Person subject to a legal protection measure
  • Pregnant, parturient or breastfeeding woman
  • Major incapable or unable to express his consent
  • Minor
  • Person with locomotor disorders (orthopedic, neurological, vascular, cardiac...) other than amputation that may significantly alter walking
  • Persons with contraindications to wearing a virtual reality helmet (uncontrolled epilepsy, wounds in an area that the helmet would cover, severe ophthalmological disorders, etc.)
  • Patients unable to participate in a group interview (qualitative study only)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Healthy volunteers
Analysis of walking on flat ground under different environmental conditions (visit 1)
performed during the inclusion visit
All assessments will be identical to the flat walking analysis: flat walking will be replaced by slope walking for all environmental conditions
Experimental: Subjects with lower limb amputations
Analysis of walking on flat ground under different environmental conditions (visit 1)
performed during the inclusion visit
All assessments will be identical to the flat walking analysis: flat walking will be replaced by slope walking for all environmental conditions
Virtual reality feedback, accompanied by a confrontation of the patients' subjective experiences (group of 5 to 10 people)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of healthy volunteers who completed the virtual reality experiment (flat walk) without complications
Time Frame: at baseline
at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2023

Primary Completion (Actual)

November 26, 2025

Study Completion (Actual)

November 26, 2025

Study Registration Dates

First Submitted

November 23, 2022

First Submitted That Met QC Criteria

December 1, 2022

First Posted (Actual)

December 2, 2022

Study Record Updates

Last Update Posted (Estimated)

December 23, 2025

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unilateral Amputation of the Lower Limb

Clinical Trials on Analysis of walking on flat ground

Subscribe